INTERNATIONAL PATENT: DAEWOONG PHARMACEUTICAL CO., LTD., 주식회사 대웅제약 FILES APPLICATION FOR "GENETICALLY MODIFIED CELL PRODUCING URSODEOXYCHOLIC ACID PRECURSOR AND METHOD FOR PRODUCING URSODEOXYCHOLIC ACID PRECURSORS USING SAME"

GENEVA, Oct. 14 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14, Jeyakgongdan 4-gil,Hyangnam-eupHwaseong-siGyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2025/004584) for "GENETICALLY MODIFIED CELL PRODUCING URSODEOXYCHOLIC ACID PRECURSOR AND METHOD FOR PRODUCING URSODEOXYCHOLIC ACID PRECURSORS USING SAME" on Apr 04, 2025. With publication no. WO/2025/211859, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is man...